The protocol is designed to evaluate children with cutaneous or systemic mastocytosis. Patients with all variants of pediatric-onset mastocytosis: urticaria pigmentosa, diffuse cutaneous mastocytosis, mastocytoma, and indolent systemic mastocytosis, are being studied. The information we are collecting from subjects enrolled in the protocol provides the much needed information required to identify factors that may be associated with disease that does not resolve. Moreover, in those children with indolent systemic mastocytosis, this protocol will identify prognostic markers for disease progression into adulthood. In our recent studies, we have thus found serum tryptase to reflect extent of disease and to serve as an important biomarker of both disease regression and progression. We have also identified unique bone marrow biopsy findings that may similarly be used to predict disease progression and may lead the way to an improved classification of pediatric onset mastocytosis.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Zip Code
Smrž, Daniel; Wilson, Todd M; Metcalfe, Dean D et al. (2012) Providing the TORC for cell cycle progression in neoplastic mast cells. Cell Cycle 11:210-1
Smrz, Daniel; Kim, Mi-Sun; Zhang, Shuling et al. (2011) mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells. Blood 118:6803-13
Castells, Mariana; Metcalfe, Dean D; Escribano, Luis (2011) Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations. Am J Clin Dermatol 12:259-70
Lee, Youl-Nam; Brandal, Stephanie; Noel, Pierre et al. (2011) KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation. Blood 117:3629-40
Uzzaman, Ashraf; Maric, Irina; Noel, Pierre et al. (2009) Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology. Pediatr Blood Cancer 53:629-34
Raymond, Wilfred W; Su, Sharon; Makarova, Anastasia et al. (2009) Alpha 2-macroglobulin capture allows detection of mast cell chymase in serum and creates a reservoir of angiotensin II-generating activity. J Immunol 182:5770-7